ACADIA PHARMACEUTICALS INC. (ACAD) /

The debt of ACADIA PHARMACEUTICALS INC. over the past 10 years

Chart ACADIA PHARMACEUTICALS INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, ACADIA PHARMACEUTICALS INC. had liquid cash of $819.69M and total debt of $0: net cash of $819.69M. It had more liquid cash than debt at all 10 year-ends shown.

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$819.69M*$0$819.69M
2024ended Dec 31, 2024$755.99M*$0$755.99M
2023ended Dec 31, 2023$438.87M*$0$438.87M
2022ended Dec 31, 2022$416.82M*$0$416.82M
2021ended Dec 31, 2021$520.71M*$0$520.71M
2020ended Dec 31, 2020$631.96M*$0$631.96M
2019ended Dec 31, 2019$697.43M*$0$697.43M
2018ended Dec 31, 2018$473.52M*$0$473.52M
2017ended Dec 31, 2017$341.34M*$0$341.34M
2016ended Dec 31, 2016$529.04M*$0$529.04M

Fiscal years as ACADIA PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ACADIA PHARMACEUTICALS INC.

Companies of a similar size

Not investment advice. This page shows what ACADIA PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.